Here are the DEF 14A proxy statements from Sabra Healthcare REIT, Inc. (SBRA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow SBRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SBRA filings page.
Sabra Health Care REIT, Inc. has issued its 2026 proxy statement for the annual stockholder meeting on June 17, 2026 at its Tustin, California headquarters. Stockholders of record on April 14, 2026 may vote in person or by Internet, phone or mail.
Key items include electing directors, ratifying PwC as independent auditor for the year ending December 31, 2026, and a non-binding advisory vote on named executive officer compensation. The board is majority independent, uses majority voting for uncontested elections, provides proxy access, has no stockholder rights plan and has opted out of certain Maryland takeover defenses.
Executive pay is heavily performance-based, with about 65% of 2025 equity grant value in relative total stockholder return units, a five-year deferral and one-year post-vesting holding period, plus stringent stock ownership requirements of 10x base salary for the CEO and 5x for other executives. The proxy also highlights sustainability reporting, board and workforce diversity and formal oversight of human capital and ESG matters.